The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.EBI
University of Colorado
Quantitative analysis of histone demethylase probes using fluorescence polarization.EBI
University of Colorado
Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.EBI
University of Colorado
Rational design and synthesis of androgen receptor-targeted nonsteroidal anti-androgen ligands for the tumor-specific delivery of a doxorubicin-formaldehyde conjugate.EBI
University of Colorado
Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.EBI
University of Colorado
Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (MEBI
University of Colorado
Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera.EBI
University of Colorado
Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.EBI
University of Colorado
Discovery of Novel Small-Molecule Inhibitors of NF-κB Signaling with Antiinflammatory and Anticancer Properties.EBI
University of Colorado
Solid form, crystalline form, and crystal form a of FXR agonist, and preparation method and application thereofBDB
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.
RNA VIRUS INHIBITOR COMPOUNDS WITH IMPROVED METABOLIC STABILITY AND USES THEREOFBDB
University of Alberta
Pyrazolylaminobenzimidazole derivatives as JAK inhibitorsBDB
Eli Lilly
N-[9-(ortho-fluorobenzyl)-2-phenyl-8-azapurin-6-yl]-amides as potent and selective ligands for A1 adenosine receptors.BDB
University of Pisa
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.BDB
Anadys Pharmaceuticals